Analysis of CXCR3 expression across the molecular subtypes revealed increased CXCR3 expression in HER2-enriched and triple-negative breast cancer subtypes, compared to the luminal subtypes (Figure 3A). The gene discussed is CXCR3; the disease is triple-negative breast carcinoma.